A detailed history of Synovus Financial Corp transactions in Vericel Corp stock. As of the latest transaction made, Synovus Financial Corp holds 11,576 shares of VCEL stock, worth $610,518. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,576
Previous 8,357 38.52%
Holding current value
$610,518
Previous $383,000 27.68%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $136,002 - $172,409
3,219 Added 38.52%
11,576 $489,000
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $709 - $899
17 Added 0.2%
8,357 $383,000
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $271,216 - $436,432
8,340 New
8,340 $433,000
Q2 2020

Aug 10, 2020

SELL
$8.5 - $15.82 $4,522 - $8,416
-532 Closed
0 $0
Q1 2020

Apr 24, 2020

BUY
$7.25 - $19.22 $3,857 - $10,225
532 New
532 $5,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.49B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.